Sputnik V Vaccine Approval Pending @WHO

SputnikVaccine Tweeted on September 2, 2021, Russia's Health Minister Mikhail Murashko indicated 'all barriers for Sputnik V vaccine authorization by the World Health Organization (WHO) have been removed, only minor administrative procedures need to be sorted.'

The WHO's Director-General @DrTedros has confirmed it, according to SputnikVaccine.

The Sputnik V (Gam-COVID-Vac) is an adenoviral-based, two-part vaccine against the SARS-CoV-2 coronavirus. Initially produced in Russia, Sputnik V uses a weakened virus to deliver small parts of a pathogen and stimulate an immune response.

Sputnik V is now produced in about twenty countries and authorized for use in 70 countries.

The WHO's landscape of COVID-19 vaccine candidates for the latest information on vaccines in clinical and pre-clinical development, generally updated twice a week. WHO's COVID-19 dashboard, updated daily, also features the number of vaccine doses administered globally.